The role of bacterial biofilms in chronic infections
Tóm tắt
Acute infections caused by pathogenic bacteria have been studied extensively for well over 100 years. These infections killed millions of people in previous centuries, but they have been combated effectively by the development of modern vaccines, antibiotics and infection control measures. Most research into bacterial pathogenesis has focused on acute infections, but these diseases have now been supplemented by a new category of chronic infections caused by bacteria growing in slime‐enclosed aggregates known as biofilms. Biofilm infections, such as pneumonia in cystic fibrosis patients, chronic wounds, chronic otitis media and implant‐ and catheter‐associated infections, affect millions of people in the developed world each year and many deaths occur as a consequence. In general, bacteria have two life forms during growth and proliferation. In one form, the bacteria exist as single, independent cells (planktonic) whereas in the other form, bacteria are organized into sessile aggregates. The latter form is commonly referred to as the biofilm growth phenotype. Acute infections are assumed to involve planktonic bacteria, which are generally treatable with antibiotics, although successful treatment depends on accurate and fast diagnosis. However, in cases where the bacteria succeed in forming a biofilm within the human host, the infection often turns out to be untreatable and will develop into a chronic state. The important hallmarks of chronic biofilm‐based infections are extreme resistance to antibiotics and many other conventional antimicrobial agents, and an extreme capacity for evading the host defences. In this thesis, I will assemble the current knowledge on biofilms with an emphasis on chronic infections, guidelines for diagnosis and treatment of these infections, before relating this to my previous research into the area of biofilms. I will present evidence to support a view that the biofilm lifestyle dominates chronic bacterial infections, where bacterial aggregation is the default mode, and that subsequent biofilm development progresses by adaptation to nutritional and environmental conditions. I will make a series of correlations to highlight the most important aspects of biofilms from my perspective, and to determine what can be deduced from the past decades of biofilm research. I will try to bridge
Từ khóa
Tài liệu tham khảo
Atlas RM, 1997, Microbial Ecology
Henrici AT, 1933, Studies of freshwater bacteria, J Bacteriol, 25, 2132, 10.1128/jb.25.3.277-287.1933
RogovskaT LazarevaMF.Microbiological characteristics of biofilm purifying hydrogen sulphide containing sewage.1961.
Zimmerli W, 2010, Biofilm Infections, 91
Semmler AB, 1999, A re‐examination of twitching motility in Pseudomonas aeruginosa, Microbiology, 145, 2863, 10.1099/00221287-145-10-2863
Reimmann C, 2002, Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1, Microbiology, 148, 923, 10.1099/00221287-148-4-923
Bjarnsholt T, 2005, Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum‐sensing dependent, Microbiology, 151, 373, 10.1099/mic.0.27463-0
Stapper AP, 2004, Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation, J Med Microbiol, 53, 679, 10.1099/jmm.0.45539-0
Matsuyama T, 1990, Surface‐active novel glycolipid and linked 3‐hydroxy fatty acids produced by Serratia rubidaea, J Bacteriol, 172, 3015, 10.1128/jb.172.6.3015-3022.1990
Pedersen SS, 1989, Purification, characterization, and immunological cross‐reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 27, 691, 10.1128/jcm.27.4.691-699.1989
Høiby N, 1974, Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response, Acta Pathol Microbiol Scand [B] Microbiol Immunol, 82, 551
Giedraitiene A, 2011, Antibiotic resistance mechanisms of clinically important bacteria, Medicina (Kaunas), 47, 137
Hoyle BD, 1991, Bacterial resistance to antibiotics: the role of biofilms, Prog Drug Res, 37, 91
Haagensen JA, 2006, Differentiation and distribution of colistin/SDS tolerant cells in Pseudomonas aeruginosa flow‐cell biofilms, J Bacteriol, 189, 28, 10.1128/JB.00720-06
Manefield M, 2002, Quorum sensing in context: out of molecular biology and into microbial ecology, Microbiology, 148, 3762, 10.1099/00221287-148-12-3762
Wu H, 2001, Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection, Microbiology, 147, 1105, 10.1099/00221287-147-5-1105
Hentzer M, 2002, Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound, Microbiology, 148, 87, 10.1099/00221287-148-1-87
Huber B, 2001, The cep quorum‐sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility, Microbiology, 147, 2517, 10.1099/00221287-147-9-2517
Kelstrup J, 1977, Microbial aggregate contamination of water lines in dental equipment and its control, Acta Pathol Microbiol Scand B, 85, 177
Larsen T, 2008, Vandkvaliteten i danske dentalunits med og uden kimanlæg, Tandlægebladet, 112, 1316
Theilade E, 1970, Denal Plaque, 27
Nyvad B, 1993, Microbial colonization of human tooth surfaces, APMIS Suppl, 32, 1
Domingue PA, 1991, The human vagina: normal flora considered as an in situ tissue‐associated, adherent biofilm, Genitourin Med, 67, 226
Høiby N, 2008, Klinisk mikrobiologi og infektionsmedicin
Marsh PD, 2009, Dental plaque as a biofilm: the significance of pH in health and caries, Compend Contin Educ Dent, 30, 76
Hodson JJ, 1955, A histopathological study of the bacterial plaque in relation to the destruction of enamel, dentine and bone with special reference to dental caries, Proc R Soc Med, 48, 641
Percival SL, 2004, Biofilms and their potential role in wound healing, Wounds, 16
Mertz PM, 2003, Cutaneous biofilms: friend or foe?, Wounds, 15, 129
Leach AJ, 2006, Antibiotics for the prevention of acute and chronic suppurative otitis media in children, Cochrane Database Syst Rev, CD004401
Rumbaugh KP, 2010, Biofilm Infections, 267
DigeI.Initial dental biofilm formation studied by confocal laser scanning microscopy and fluorescence in situ hybridization. PhD Thesis Denmark:Faculty of Health Sciences Aarhus University 2008.
Marsh PD, 1991, Sugar, fluoride, pH and microbial homeostasis in dental plaque, Proc Finn Dent Soc, 87, 515
Kobayashi N, 2007, Brief ultrasonication improves detection of biofilm‐formative bacteria around a metal implant, Clin Orthop Relat Res, 457, 210, 10.1097/BLO.0b013e3180312042
Wilson M, 2005, The Respiratory System and its Indigenous Microbiota. Microbial Inhabitants of Humans, 128
Evans AS, 1976, Causation and disease: the Henle‐Koch postulates revisited, Yale J Biol Med, 49, 175
Høiby N, 1977, Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis, Scand J Respir Dis, 58, 65
Høiby N, 1975, Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis, Scand J Respir Dis, 56, 38
LobmannR.Cytokine analyses in wound fluids of DFS: an objective reflection of inflammation and the state of healing.2005. DFSG annual meeting 2005 abstract number 07.
Dong Z, 2000, Membrane‐type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa, Invest Ophthalmol Vis Sci, 41, 4189
Pedersen SS, 1990, Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis, J Clin Microbiol, 28, 747, 10.1128/jcm.28.4.747-755.1990
Kronborg G, 1992, Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients, J Clin Microbiol, 30, 1848, 10.1128/jcm.30.7.1848-1855.1992
Doring G, 1986, Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease, Clin Exp Immunol, 64, 597